Task: Answer Verification
Input (English): Question: Does hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 affect viral response in patients treated with peginterferon alpha-2a ( 40KD ) ( PEGASYS ) plus ribavirin ( COPEGUS ) for 16 or 24 weeks?
Answer: Steatosis did not influence the efficacy of treatment in our study population. Baseline viral load is a confounding factor, particularly in patients infected with genotype 3 and once baseline viral load was accounted for, the association between steatosis and SVR was not relevant.
Output (English): no